← Back


Friday, 05 October 2012

Cancer treatment research by ICN group covered in newspaper Ara

Catalan newspaper publishes story about work led by ICREA Research Prof Victor Puntes on use of gold nanoparticles for delivery of the chemotherapeutic agent cisplatin

Catalan news daily Ara has just published a story covering work done by ICREA Professor Victor Puntes, who leads ICN’s Inorganic Nanoparticles Group, and colleagues on the use of gold nanoparticles for delivery of the chemotherapeutic agent cisplatin. The article, entitled“Or per combatre el cancer” (Gold for fighting cancer)”, discusses the latest developments in this strategy and explains some of the behind it.Cisplatin is a widely used chemotherapeutic drug which is deadly to cancer cells, but implies numerous side-effects. Thus, there has been a push to find either a replacement drug for cisplatin or better ways of administering it through the body—namely, so that it selectively kills only cancer cells while leaving healthy tissue alone. Dr Puntes and his co-workers have designed and developed a drug delivery system in which gold nanoparticles are used to deliver cisplatin directly to the tumour site, while circumventing the classical administration route followed by the drug when it is injected alone intravenously. Their strategy has so far proven effective in animal models of cancer, and the team hopes to ultimately advance their gold nanoparticle system into clinical (human) trials. The article Or per combatre el cancer, published in Ara on 30 Sep 2012, can be accessed here.